ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-2.13%
↑ 71% vs avg
Percentile
P46
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-7.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -2.13% |
| Q3 2025 | 13.59% |
| Q2 2025 | 7.17% |
| Q1 2025 | -0.89% |
| Q4 2024 | 13.79% |
| Q3 2024 | 1.58% |
| Q2 2024 | 6.20% |
| Q1 2024 | 7.19% |
| Q4 2023 | -31.88% |
| Q3 2023 | -9.56% |
| Q2 2023 | 5.38% |
| Q1 2023 | 7.07% |
| Q4 2022 | -12.56% |
| Q3 2022 | 11.67% |
| Q2 2022 | -21.78% |
| Q1 2022 | -4.59% |
| Q4 2021 | 1.48% |
| Q3 2021 | -4.48% |
| Q2 2021 | -15.09% |
| Q1 2021 | -4.97% |
| Q4 2020 | -55.72% |
| Q3 2020 | 19.62% |
| Q2 2020 | -47.95% |
| Q1 2020 | -108.98% |
| Q4 2019 | 10.18% |
| Q3 2019 | 1.52% |
| Q2 2019 | -28.67% |
| Q1 2019 | 6.81% |
| Q4 2018 | 20.14% |
| Q3 2018 | -8.02% |
| Q2 2018 | -4.87% |
| Q1 2018 | -13.72% |
| Q4 2017 | -34.61% |
| Q3 2017 | 32.22% |
| Q2 2017 | -48.65% |
| Q1 2017 | 6.47% |
| Q4 2016 | -0.66% |
| Q3 2016 | -28.70% |
| Q2 2016 | 6.27% |
| Q1 2016 | 20.11% |